Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs.

MLA

Giraudel, J. M., et al. “Development and Validation of a New Model of Inflammation in the Cat and Selection of Surrogate Endpoints for Testing Anti-Inflammatory Drugs.” Journal of Veterinary Pharmacology & Therapeutics, vol. 28, no. 3, June 2005, pp. 275–85. EBSCOhost, https://doi.org/10.1111/j.1365-2885.2005.00639.x.

APA

Giraudel, J. M., Diquelou, A., Lees, P., & Toutain, P. L. (2005). Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs. Journal of Veterinary Pharmacology & Therapeutics, 28(3), 275–285. https://doi.org/10.1111/j.1365-2885.2005.00639.x

Chicago

Giraudel, J. M., A. Diquelou, P. Lees, and P. L. Toutain. 2005. “Development and Validation of a New Model of Inflammation in the Cat and Selection of Surrogate Endpoints for Testing Anti-Inflammatory Drugs.” Journal of Veterinary Pharmacology & Therapeutics 28 (3): 275–85. doi:10.1111/j.1365-2885.2005.00639.x.